Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it will host a live conference call and webcast on Thursday, November 2, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and provide a general business update.

A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the completion of the event.

About Karuna Therapeutics Karuna Therapeutics is a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by serious mental illness. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

Investors: Alexis Smith +1 (617) 352-9917 asmith@karunatx.com

Media: Julie Ciardiello +1 (917) 647-0159 julie.ciardiello@karunatx.com

Karuna Therapeutics (NASDAQ:KRTX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Karuna Therapeutics 차트를 더 보려면 여기를 클릭.
Karuna Therapeutics (NASDAQ:KRTX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Karuna Therapeutics 차트를 더 보려면 여기를 클릭.